Only chemotherapy had an influence in primary GBM, where treated patients showed higher LRIG3 mRNA levels compared to those without treatment (1.993 ± 1.602 vs. 0.862 ± 0.412, p = 0.0066 Figure 7H). Here, LRIG3 is linked to glioblastoma.